bad debt and doubtful accounts was mainly from the expansion of our loan portfolio and increased in writing off the bad debt. Moreover, the Company has developed a new collection to improve debt

or reasonable, and not affecting the rights of the unitholders significantly. (5) provision that a revision to the commitment in any case shall be in writing with the binding signature of the

sanctions imposed by the CSC will take effect once offenders sign a letter of consent, agreeing to comply with the sanctions. If any offenders refuse to consent, the SEC will submit the cases in writing to

transaction to the Stock Exchange of Thailand (the “SET”) pursuant to the Acquisition and Disposition Notifications; and (2) notify the information in writing to the shareholders of the Company within 21 days

Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales

year to be in parallel with the plunge in sales revenue. Nevertheless, some of the sales expenses did not adjust promptly and did not fully mirror the slowdown in revenue as there is a lead time for

ongoing outbreak of COVID–19, forcing many customers to adjust their working method which have an effect on the operation and delivery of the Company's projects that cause the operation to be delayed than

reducing production cost and also negotiating with customers to review and adjust selling price every quarter. 2.2. Distribution costs for 2018 was in the amount of 4.95 million baht, increased by 1.16

with the plunge in sales revenue. Nevertheless, some of the sales expenses did not adjust promptly and did not fully mirror the slowdown in revenue as there is a lead time for certain expenses that the

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change